← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2020Last known activity
Nov 11, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 5 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT06100432Overall official - principal investigatorPhase 4Nov 11, 2023
- NCT06100432Reponsible party - principal investigatorPhase 4Nov 11, 2023
- NCT06100432Lead sponsorPhase 4Nov 11, 2023
- NCT04689958Lead sponsorPhase 2/Phase 3Nov 3, 2020
- NCT04689971Reponsible party - principal investigatorPhase 2/Phase 3Nov 3, 2020
- NCT04689971Overall official - principal investigatorPhase 2/Phase 3Nov 3, 2020
- NCT04689971Lead sponsorPhase 2/Phase 3Nov 3, 2020
- NCT04689984Lead sponsorPhase 2/Phase 3Nov 3, 2020
- NCT04689958Reponsible party - principal investigatorPhase 2/Phase 3Nov 3, 2020
- NCT04689958Overall official - principal investigatorPhase 2/Phase 3Nov 3, 2020
- NCT04689984Reponsible party - principal investigatorPhase 2/Phase 3Nov 3, 2020
- NCT04689984Overall official - principal investigatorPhase 2/Phase 3Nov 3, 2020
- NCT04425590Reponsible party - principal investigatorPhase 2/Phase 3Apr 1, 2020
- NCT04425590Overall official - principal investigatorPhase 2/Phase 3Apr 1, 2020
- NCT04425590Lead sponsorPhase 2/Phase 3Apr 1, 2020
Details
- Last known activity
- Nov 11, 2023